Pharmaceutical company AvKare has issued a voluntary recall on several of its over-the-counter products for dry and irritated ...

Q1 2025 Earnings Call Transcript May 14, 2025 Operator: Good day and thank you for standing by. Welcome to the Nyxoah First ...

Zhong Li’s extensive history with the FDA offers crucial lessons on how companies in the pharmaceutical and biopharmaceutical sectors should approach inspection preparedness.  As an experienced FDA ...

A settlement involving federal prosecutors and Brazilian meat packers has helped wean much of the country's beef supply chain ...

Gain exclusive insights into Nyxoah's Q1 2025 earnings highlights, FDA progress, and U.S. launch strategy for their Genio system.

On May 6, the US Food and Drug Administration (FDA) announced plans to expand its use of unannounced inspections at foreign manufacturing ...

More than 70,000 cases of ophthalmic products are being recalled for manufacturing deviations, according to a press release by distributor AvKARE. The recalled products, which include eye drops and ...

The pharmaceutical testing lab BRS Analytical Service recalled products used to relieve dry and irritated eyes after ...

The FDA has said it plans to conduct more unannounced inspections at foreign facilities that produce food and medical products intended for Americans.

Over-the-counter ophthalmic products were voluntarily recalled due to a manufacturing deviation discovered during a U.S. Food ...

The expansion builds upon the agency’s Office of Inspection and Investigations Foreign Unannounced Inspection Pilot program ...

On May 6, 2025, the U.S. Food and Drug Administration (FDA) announced that it intends to expand its use of unannounced inspections at ...